SEARCH ARTICLES



LATEST ARTICLES

Table of Contents

2019 Month : December Volume : 8 Issue : 52 Page : 3968-3971

The Study of Tadalafil and Tamsulosin as Monotherapy for Lower Urinary Tract Symptoms Due to Benign Hyperplasia of Prostate.

Sudhakaran Selvaraj1, Senthil Kumar Sivalingam2

1Department of Urology, Government Chengalpattu Medical College and Hospital, Chengalpattu, Tamilnadu, India.
2Department of Urology, Government Chengalpattu Medical College and Hospital, Chengalpattu, Tamilnadu, India.

References :

1

Shapiro E, Hartanto V, Lepor H. The response to alpha blockade in benign prostatic hyperplasia is related to the percent area density of prostate smooth muscle. Prostate 1992;21(4):297-307.               

CrossRef | Google Scholar | PubMed
2

Chapple C. Medical treatment for benign prostatic hyperplasia. BMJ 1992;304(6836):1198-9.               

CrossRef | Google Scholar | PubMed
3

Montorsi F. Profile of Silodosin. Eur Urol Suppl 2010;9:491-500.

4

Rosen R, O'Leary M, Altwein J, et al. luts and male sexual dysfunction: the multi-national survey of the ageing male (MSAM-7). European Urology Supplements 2003;2(1):94.            

5

AUA Practice Guidelines Committee. AUA guideline on the management of BPH. Chap – 1: Diagnosis and treatment recommendations. J Urol 2003;170(2 Pt 1):530-47.                

CrossRef | Google Scholar | PubMed
6

Sairam K, Kulinskaya E, McNicholas TA, et al. Sildenafil influences lower urinary tract symptoms. BJU Int 2002;90(9):836-9.            

CrossRef | Google Scholar | PubMed
7

Mcvary KT, Monnig W, Camps JL Jr, et al. Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial. J Urol 2007;177(3):1071-7.                

CrossRef | Google Scholar | PubMed
8

Roehrborn CG. Benign prostatic hyperplasia: an overview. Rev Urology 2005;7 Suppl 9:S3-S14.                    

CrossRef | Google Scholar | PubMed
9

Debruyne FM. Alpha blockers: are all created equal? Urology 2000;56(5 Suppl 1):20-2.               

CrossRef | Google Scholar | PubMed
10

Bortz WM 2nd, Wallace DH, Wiley D. Sexual function in 1,202 aging males: differentiating aspects. J Gerontol A Biol Sci Med Sci 1999;54(5):M237-41.              

CrossRef | Google Scholar | PubMed
11

Broderick GA, Brock GB, Roehrborn CG, et al. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia in men with or without erectile dysfunction. Urology 2010;75(6):1452-8.             

CrossRef | Google Scholar | PubMed